» Articles » PMID: 29695381

Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure

Abstract

Background: Single measurements of left ventricular filling pressure at rest lack sensitivity for identifying heart failure with preserved ejection fraction (HFpEF) in patients with dyspnea on exertion. We hypothesized that exercise hemodynamic measurements (ie, changes in pulmonary capillary wedge pressure [PCWP] indexed to cardiac output [CO]) may more sensitively differentiate HFpEF and non-HFpEF disease states, reflect aerobic capacity, and forecast heart failure outcomes in individuals with normal PCWP at rest.

Methods And Results: We studied 175 patients referred for cardiopulmonary exercise testing with hemodynamic monitoring: controls (n=33), HFpEF with resting PCWP≥15 mm Hg (n=32), and patients with dyspnea on exertion with normal resting PCWP and left ventricular ejection fraction (DOE-nlrW; n=110). Across 1835 paired PCWP-CO measurements throughout exercise, we used regression techniques to define normative bounds of "PCWP/CO slope" in controls and tested the association of PCWP/CO slope with exercise capacity and composite cardiac outcomes (defined as cardiac death, incident resting PCWP elevation, or heart failure hospitalization) in the DOE-nlrW group. Relative to controls (PCWP/CO slope, 1.2±0.4 mm Hg/L/min), patients with HFpEF had a PCWP/CO slope of 3.4±1.9 mm Hg/L/min. We used a threshold (2 SD above the mean in controls) of 2 mm Hg/L/min to define abnormal. PCWP/CO slope >2 in DOE-nlrW patients was common (n=45/110) and was associated with reduced peak Vo (<0.001) and adverse cardiac outcomes after adjustment for age, sex, and body mass index (hazard ratio, 3.47; =0.03) at a median 5.3-year follow-up.

Conclusions: Elevated PCWP/CO slope during exercise (>2 mm Hg/L/min) is common in DOE-nlrW and predicts exercise capacity and heart failure outcomes. These findings suggest that current definitions of HFpEF based on single measures during rest are insufficient and that assessment of exercise PCWP/CO slope may refine early HFpEF diagnosis.

Citing Articles

Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.

Tarras E, Singh I, Kreiger J, Joseph P J Clin Med. 2025; 14(3).

PMID: 39941482 PMC: 11818252. DOI: 10.3390/jcm14030804.


Prognostic relevance of exercise pulmonary hypertension: results of the multicentre PEX-NET Clinical Research Collaboration.

Kovacs G, Humbert M, Avian A, Lewis G, Ulrich S, Vonk Noordegraaf A Eur Respir J. 2024; 64(6).

PMID: 39603672 PMC: 11684422. DOI: 10.1183/13993003.00698-2024.


Exercise Hemodynamics in Heart Failure with Preserved Ejection Fraction.

Sarma S Heart Fail Clin. 2024; 21(1):27-34.

PMID: 39550078 PMC: 11569380. DOI: 10.1016/j.hfc.2024.08.003.


[Highlights 57th SEPAR Congress].

Martinez Menaca A, Garcia Moyano M, Sanchez-Salcedo P, Cascon-Hernandez J, Sante Diciolla N, Munoz-Ezquerre M Open Respir Arch. 2024; 6(4):100360.

PMID: 39351171 PMC: 11440302. DOI: 10.1016/j.opresp.2024.100360.


Definition, classification and diagnosis of pulmonary hypertension.

Kovacs G, Bartolome S, Denton C, Gatzoulis M, Gu S, Khanna D Eur Respir J. 2024; 64(4).

PMID: 39209475 PMC: 11533989. DOI: 10.1183/13993003.01324-2024.


References
1.
Haykowsky M, Brubaker P, John J, Stewart K, Morgan T, Kitzman D . Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2011; 58(3):265-74. PMC: 3272542. DOI: 10.1016/j.jacc.2011.02.055. View

2.
Argiento P, Vanderpool R, Mule M, Russo M, DAlto M, Bossone E . Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest. 2012; 142(5):1158-1165. PMC: 3494470. DOI: 10.1378/chest.12-0071. View

3.
Galie N, Hoeper M, Humbert M, Torbicki A, Vachiery J, Barbera J . Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the.... Eur Heart J. 2009; 30(20):2493-537. DOI: 10.1093/eurheartj/ehp297. View

4.
Reddy Y, Lewis G, Shah S, LeWinter M, Semigran M, Davila-Roman V . INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. Circ Heart Fail. 2017; 10(5). PMC: 5484533. DOI: 10.1161/CIRCHEARTFAILURE.117.003862. View

5.
Poole D, Richardson R, Haykowsky M, Hirai D, Musch T . Exercise limitations in heart failure with reduced and preserved ejection fraction. J Appl Physiol (1985). 2017; 124(1):208-224. PMC: 5866447. DOI: 10.1152/japplphysiol.00747.2017. View